EULAV Asset Management’s Teladoc Health TDOC Stock Holding History

EULAV Asset Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-18,000	Closed	-$965K	–	312
2019 Q1	$965K	Hold	18,000	–	–	0.04%	254
2018 Q4	$892K	Hold	18,000	–	–	0.04%	238
2018 Q3	$1.55M	Hold	18,000	–	–	0.07%	211
2018 Q2	$1.04M	Hold	18,000	–	–	0.05%	231
2018 Q1	$725K	Buy	18,000 +1,000	+6%	+$37.7K	0.03%	247
2017 Q4	$592K	Hold	17,000	–	–	0.03%	263
2017 Q3	$564K	Hold	17,000	–	–	0.03%	270
2017 Q2	$590K	Buy	+17,000	New	+$495K	0.03%	264

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

ZCI

Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

EULAV Asset Management's TDOC Position: Q2 2019 in Review

EULAV Asset Management sold out of Teladoc Health (TDOC) in Q2 2019, closing a stake of 18,000 shares — an estimated $965K sold.

EULAV Asset Management first reported a position in TDOC in Q2 2017 and held it in 8 quarters. The position peaked at $1.55M in Q3 2018. 371 funds tracked by Wall St. Rank hold TDOC as of Q2 2019.

EULAV Asset Management reported no remaining Teladoc Health position as of Q2 2019 after selling out during the quarter.
EULAV Asset Management sold 18,000 Teladoc Health shares in Q2 2019, an estimated $965K.
EULAV Asset Management first reported a position in Teladoc Health in Q2 2017 and held it in 8 quarters.
EULAV Asset Management's Teladoc Health position peaked at $1.55M in Q3 2018.
371 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2019.

Based on EULAV Asset Management's 13F filing for Q2 2019, filed 5 Aug 2019.